Form 8-K - Current report:
SEC Accession No. 0001396814-24-000103
Filing Date
2024-08-09
Accepted
2024-08-09 15:23:04
Documents
15
Period of Report
2024-08-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20240809.htm   iXBRL 8-K 24883
2 EX-99.1 pcrx-p4pressreleaseexhibit.htm EX-99.1 13090
6 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01a.jpg GRAPHIC 27796
  Complete submission text file 0001396814-24-000103.txt   204883

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20240809.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20240809_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20240809_pre.xml EX-101.PRE 12518
17 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20240809_htm.xml XML 2733
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 241192210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)